Back to results
UnknownPhase 1

TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer

NCT03720431

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Liverpool Hospital

Liverpool, New South Wales, Australia

+1 additional location

View on ClinicalTrials.gov
TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer — TrialFind